Figure 1.
Comparison of serum arylesterase activity among diabetic and non-diabetic patients with or without HF. Diabetic patients tend to have lower arylesterase activity than the non-diabetic controls both in the population with (140.15 ± 45.88 vs. 166.97 ± 49.19 μmol/L/min/mL, P = 0.002) and without HF (179.44 ± 61.40 vs. 199.78 ± 70.51 μmol/L/min/mL, P = 0.005). Serum arylesterase activity is significantly decreased in both diabetic and non-diabetic patients when comorbid with HF. *P < 0.05; **P < 0.01.